New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 29, 2014
05:44 EDTBIIBBiogen upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded Biogen to Overweight citing upside potential from the company's multiple sclerosis franchise as well as its mid-stage pipeline opportunities. The firm raised its price target for shares to $375 from $300.
News For BIIB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 15, 2015
07:29 EDTBIIBOutlook for Biogen trials positive , says RBC Capital
Subscribe for More Information
January 14, 2015
07:05 EDTBIIBIsis Pharmaceuticals earns $7M from Biogen for advancing muscular atrophy study
Subscribe for More Information
January 13, 2015
13:09 EDTBIIBBiogen CEO says company has strengthened R&D, to stay active in M&A
Subscribe for More Information
January 11, 2015
20:06 EDTBIIBBiogen acquires U.K.-based Convergence for up to $675M
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use